TipRanks (Tue, 15-Sep 7:50 AM ET)
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS) and Cardiff Oncology (CRDF)
TipRanks (Mon, 14-Sep 11:30 AM ET)
Addus HomeCare announces agreement to acquire personal care division of AccentCare
Seeking Alpha News (Mon, 14-Sep 8:30 AM ET)
Addus HomeCare Announces a Definitive Agreement to Acquire Personal Care Division of AccentCare
Business Wire (Mon, 14-Sep 8:00 AM ET)
Addus HomeCare to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
Business Wire (Tue, 8-Sep 12:00 PM ET)
Business Wire (Mon, 10-Aug 9:00 AM ET)
Addus HomeCare Announces Second Quarter 2026 Financial Results
Business Wire (Mon, 3-Aug 4:05 PM ET)
Addus HomeCare Announces Second Quarter 2026 Earnings Release and Conference Call
Business Wire (Mon, 20-Jul 11:00 AM ET)
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.
Addus Homecare trades on the NASDAQ stock market under the symbol ADUS.
As of September 16, 2026, ADUS stock price climbed to $118.51 with 167,868 million shares trading.
ADUS has a beta of 0.38, meaning it tends to be less sensitive to market movements. ADUS has a correlation of 0.03 to the broad based SPY ETF.
ADUS has a market cap of $2.21 billion. This is considered a Mid Cap stock.
Last quarter Addus Homecare reported $377 million in Revenue and $1.73 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.08.
In the last 3 years, ADUS traded as high as $136.72 and as low as $78.35.
The top ETF exchange traded funds that ADUS belongs to (by Net Assets): VTI, VXF, SPSM, VTWO, DFAT.
ADUS has underperformed the market in the last year with a return of +8.5%, while SPY returned +15.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ADUS shares. However, ADUS has outperformed the market in the last 3 month and 2 week periods, returning +25.0% and +3.5%, while SPY returned +0.1% and -1.0%, respectively. This indicates ADUS has been having a stronger performance recently.
ADUS support price is $113.79 and resistance is $117.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADUS shares will trade within this expected range on the day.